medigraphic.com

2008, Number 1

<< Back Next >>

Rev Fac Med UNAM 2008; 51 (1)

Research strategies in the development of a vaccine against syphilis

Meléndez-Herrada E, Ramírez M, B Sánchez DG, Cravioto A

Language: Spanish
References: 27
Page: 18-23
PDF size: 151.31 Kb.


Text Extraction

No abstract


REFERENCES

  1. Antal MG, Lukehart AS, Meheus ZA. The endemic treponematoses. Microbes Infec 2002; 4: 83-94.

  2. Fieldsteel AH, Cox DL, Moeckli RA. Cultivation of virulent Treponema pallidum in tissue culture. Infect Immun 1981; 32: 908-915.

  3. Bishop NH, Miller JN. Humoral immunity in experimental syphilis I. The demonstration of resistance conferred by passive immunization. J Immunol 1976; 117: 191-196.

  4. Bishop NH, Miller JN. Humoral immunity in experimental syphilis II. The relationship of neutralizing factors in immune sera to acquired resistance. J Immunol 1976; 117: 197-207.

  5. Salazar CJ, Hazlett ROK, Radolf DJ. The immune response to infection with Treponema pallidum the stealth pathogen. Microbes Infec 2002; 4: 1133-1140.

  6. Cullen PA, Cameron CE. Progress toward an effective syphilis vaccine: the past, present, and future. Expert Rev Vaccines 2006; 5: 67-80.

  7. Fraser CM, Norris SJ, Weinstock GM, White O et al. Complete genome sequence of Treponema pallidum, the syphilitic spirochete. Science 1998; 281: 375-388.

  8. Hazlett KR, Rusnak F, Kehres DG, Bearden SW, La Vake CJ, La Vake ME, Maguire ME, Perry RD, Radolf JD. The Treponema pallidum tro operon encodes a multiple metal transporter a zinc dependant transcriptional repressor and a semiautomously expressed phosphoglycerate mutase. J Biol Chem 2003; 278: 20687-20694.

  9. Hazlett KR, Cox DL, Sikkink RA, Auch´ere F, Rusnak F, Radolf JD. Contribution of neelaredoxin to oxygen tolerance by Treponema pallidum. Methods Enzymol 2002; 353: 140-156.

  10. Wagner Von Jauregg J. Uber die einwirkung der Malaria auf die progressive paralyse. Psychiatr Neurol Wochenschr 1918; 20: 132.

  11. Porcella SF, Schwan TG. Borrelia burgdorferi and Treponema pallidum: A comparison of functional genomics environmental adaptations and pathogenic mechanisms. Journal Clin Invest 2001; 107: 651-656.

  12. Cameron CE, Brown EL, Kuriowa MJ, Schnapp LM, Brouwer NL. Treponema pallidum fibronectin binding proteins. J Bacteriol 2004; 186: 7019-7022.

  13. Chung KY, Kim KS, Lee MG, Chang NS, Lee JB. Treponema pallidum induces up-regulation of interstitial collagenase in human dermal fibroblast. Acta Derm Venereol 2002; 82: 174-178.

  14. Bouis DA, Popova TG, Takashima A, Norgard MV. Dendritic cells phagocytosis are activated by Treponema pallidum. Infect Immun 2001; 69: 518-528.

  15. LaFond ER, Centurion-Lara A, Godornes Ch, Van Voorhis CW. TprK sequence diversity accumulates during infection of rabbits with Treponema pallidum subsp. pallidum Nichols strain. Infect Immun 2006; 74: 1896-1906.

  16. Seshadri R, Myers SAG, Tettlin H, Eisen AJ et al. Comparison of the genome of the oral pathogen Treponema denticola with other spirochaete genomes. Proc Natl Acad Sci USA 2004; 101: 5646-5651.

  17. Haake AD. Spirochaetal lipoproteins and pathogenesis. Microbiology 2000; 146: 1491-1504.

  18. Garbon S, Forsberg A, Wolf-Watz H, Kihlberg MB. Identification of novel virulence associated genes via genome analysis of hypothetical genes. Infect Immun 2004; 72: 1333-1340.

  19. Pizza M, Scarlato V, Mastignanni V, Giulani MM, Aricó B, Comanduci M, Jennings GT, Baldi L et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287: 1816-1820.

  20. http://www.epivax.com/matriarch/default.asp

  21. Mc kevitt M, Brinkman BM, Mc Louhlin M, Perez C, Howell KJ, Weinstock MG, Norris JJ, Palzkill T. Genome scale identification of Treponema pallidum antigens. Infect Immun 2005; 73: 4445-4450.

  22. Ivory C, Chadee K. DNA vaccines: designing strategies against parasitic infections. Genet Vaccines Ther 2004; 2: 17.

  23. Thompson AS, Elliott LS, Sherrit AM, Sproat WK et al. Recombinant polyepitope vaccines for the delivery of multiple CD+8 cytotoxic T-Cell epitopes. J Immunol 1996; 157: 822-826.

  24. Metzger M, Michalska E, Podwinska J, Smogov W. Immunogenetic properties of the protein component of Treponema pallidum. B J Vener Dis 1969; 45: 299-303.

  25. Borenstein LA, Radolf JD, Fehniger TE, Blanco DR, Millar JN, Lovett MA. Immunization of rabbits with the recombinant Treponema pallidum surface antigen 4D alter the course of experimental syphilis. J Immunol 199; 140: 2415-2421.

  26. Wicher K, Schouls LM, Wicher V, Van Embden JD, Nakeeb SS. Immunization of guinea pigs with recombinant tmpB antigens induces protection against challenge infection with Treponema pallidum Nichols. Infect Immun 1991; 59: 4343-4348.

  27. http://www.niaid.nih.gov/dmid/vaccines/jordan20/




2020     |     www.medigraphic.com